Categories
Sai Life Sciences Limited — Updates, 14-05-2026: Press Release
14-05-2026 · 11:28 pm
Sai Life Sciences (SAILIFE) FY26: Revenue +29% to ₹2,192 Cr, EBITDA +56% to ₹661 Cr, Net Profit +109% to ₹355 Cr. Strong execution and deepening pharma ties drove growth, with significant investments in CRDMO capabilities.
No comments yet. Be the first to comment!